Evaluation of adherence to highly active antiretroviral therapy in adults in Jamaica

West Indian Medical Journal

Volumn 57, Issue 3, 2008, Pages 293-297

  Harvey, K M ^a   Carrington, D ^a   Duncan, J ^a   Figueroa, J P ^a   Hirschorn, L ^b   Manning, D ^a   Jackson, S ^a  

^a Ministry of Health   (Jamaica)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; EDUCATIONAL STATUS; FAMILY LIFE; FEMALE; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JAMAICA; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT COUNSELING; RECALL; RISK FACTOR; SELF REPORT; SLEEP; SOCIAL STATUS; UNEMPLOYMENT; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CROSS-SECTIONAL STUDIES; DATA COLLECTION; FEMALE; HIV INFECTIONS; HUMANS; JAMAICA; MALE; MEDICATION ADHERENCE; QUESTIONNAIRES; RISK FACTORS; YOUNG ADULT;

EID: 55749094472     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Figueroa JP, Ward E, Walters C, Ashley DE, Wilks RJ. High risk health behaviours among adult Jamaicans. West Indian Med J 2005; 54: 70-6.
2. National HIV/STI Programme, Ministry of Health, Kingston, Jamaica. Available at: www.jamaica-nap.org.
3. Scientific Committee on AIDS. Recommended principles of antiretroviral therapy in HIV disease. Jan 2005. Available at http://www.aids.gov.hk
4. Sterne JA, Hernan MA, Ledergerber B, Tilling K, Weber R, Sendi P et al. Long-term effectivieness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet 2005; 366: 378-84.
5. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853-60.
6. Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK. Panel on Clinical Practices for Treatment of HIV. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Ann Intern Med 2002; 137: 381-433.
7. CASCADE collaboration. Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet 2003; 362: 1267-74.
8. Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, D'Arminio MA et al. Decline in the AIDS and death rates in the EUROSIDA study: an observational study. Lancet 2003; 362: 22-9.
9. Gulick RM. HIV treatment strategies: planning for the long term. JAMA 2004; 998; 279: 957-9.
10. Deeks SG. Treatment of antiretroviral-drug-resistant HIV-1 infection. Lancet 2003; 362: 2002-1
11. Vandamme AM, Sonnerborg A, Ait-Khaled M. Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther 2004; 9: 829-48.
12. Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JS. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 × 10(9) cells/L. Ann Intern Med 2003; 139: 810-6.
13. Horne R, Cooper V, Gellaitry G, Leake H, Fisher M. Patients perception of highly active antiretroviral therapy in relation to treatment uptake and adherence. JAIDS 2007; 45: 334-41.
14. Catt S, Stygall J, Catalan J. Acceptance of zidovudine (AZT) in early HIV disease: The role of health beliefs. AIDS Care 1995; 7: 229-35.
15. Chesney M. Adherence to HAART regimens, AIDS Patient Care STDS 2003; 17: 169-77.
16. Chesney MA, Ickovics JR, Chambers DB. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 2000; 12: 255-66.
17. Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr 2006; 43 Suppl 1: S79-87.
18. Nieuwkerk, PT, Oort FJ (abstract). Self-reported adherence to antiretroviral therapy for HIV-1 infection and virological treatment response: a meta-analysis. JAIDS 2005; 38: 445-8.
19. Arnsten JH, Demas PA, Farzadegan H, Grant RW, Gourevitch MN, Chang CJ et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis 2001; 33: 1417-23.
20. Fairley CK, Permana A, Read TR. Long term utility of measuring adherence by self report compared to pharmacy record in a routine clinic setting. HIV Med 2005; 6: 366-9.
21. Statistical Institute of Jamaica (STATIN). Employment and earnings and hours worked in large establishments 2002 - 2005, Published by STATIN; 2007.
22. Harvey K, Jackson S, Hirshorn L. Adherence to Highly Active Antiretroviral Therapy (HAART) in Jamaica (abstract). NIMH/IAPAC International Conference on HIV Treatment Adherence; 2006.
23. Bartlett J, Gallant J. Medical Management of HIV Infection 2005-2006 edition, John Hopkins Medicine Health Publishing Business Group; 2005.